A patient with metastatic lung adenocarcinoma harboring concurrent EGFR L858R, EGFR germline T790M, and PIK3CA mutations: the challenge of interpreting results of comprehensive mutational testing in lung cancer

Documenti analoghi

• Unusual metachronous lung adenocarcinomas harboring EGFR L858R/T790M mutations: A case report
  di: Pei, Guotian, et al.
  Pubblicazione: (2020)
• EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
  di: Kim, Minhye, et al.
  Pubblicazione: (2021)
• Case Report: Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients with Lung Adenocarcinoma
  di: Lou, Yanyan, et al.
  Pubblicazione: (2015)
• L858R-positive lung adenocarcinoma with KRAS G12V, EGFR T790M and EGFR L858R mutations: A case report
  di: XIANG, XIANHONG, et al.
  Pubblicazione: (2015)
• Acquired Gefitinib-Resistant Mutation of EGFR in a Chemonaive Lung Adenocarcinoma Harboring Gefitinib-Sensitive Mutation L858R
  di: Gow, Chien-Hung, et al.
  Pubblicazione: (2005)